Reid Hoffman is leaving Microsoft’s board to go ‘founder mode’ with startup Manus
Quick Answer
Reid Hoffman is resigning from Microsoft's board after a decade to focus on his AI drug discovery startup, Manus.
Quick Take
Reid Hoffman is resigning from Microsoft's board after a decade to focus on his AI drug discovery startup, Manus. This shift marks a significant transition for Hoffman, who aims to leverage his expertise in AI to innovate in the pharmaceutical sector.
Key Points
- Hoffman spent a profitable decade on Microsoft's board.
- He is now focusing on his startup Manus, specializing in AI drug discovery.
- This move highlights a trend of tech leaders returning to startup roots.
- Manus aims to innovate within the pharmaceutical industry using AI.
Article Excerpt
From source RSS / original summaryAfter a very profitable decade on Microsoft's board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.
Reader Mode unavailable (could not extract clean content).
Want this in your inbox every morning?
Daily brief at your local 8am — bilingual EN/中文, free.
More from TechCrunch
See more →
After Nvidia’s $20B not-acqui-hire, AI chip startup Groq reportedly raising $650M
AI chip startup Groq is reportedly raising $650 million to shift its focus from hardware to AI inference, enhancing how AI models respond to prompts. This move follows Nvidia's recent $20 billion not-acqui-hire, indicating a competitive landscape in AI chip development.
